Human papillomavirus detection and typification through PCR-RFLP;Detección y tipificación de virus del papiloma humano (VPH) mediante PCR- RFLP

Revista de Obstetricia y Ginecologia de Venezuela

Volumn 68, Issue 1, 2008, Pages 25-31

  Vega, Militza Quintero ^a,b   Gómez, Jhon Fredy Cruz ^a   Bastidas, Marco ^a   Márquez, Lusmary ^a   Pons, Juan Puig ^a  

^a FACULTAD DE CIENCIAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Cervical cancer; Cervical infection; Human papillomavirus; PCR RFLP

Indexed keywords

EID: 49249120959     PISSN: 00487732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Zür Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians. 1996;111:581-587.
2. de Villiers EM. Human Pathogenic Papillomavirus types: An update. En: Zür Hausen H, editor. Currents topics in microbiology and inmunology. Human Pathogenic Papillomavirus. Springer-Verlag Berling Heidelberg. 1994.p.1-11.
3. Lörincz A, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RI. Human Papillomavirus infection of the cervix: Relative Risk associations of 15 common anogenital types. Obstet Gynecol. 1992;79:328-337.
4. Baker T, Newcomb W, Olson N, Cowsert L, Olson C, Brown J. Structure of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 1991;60:1445-1446.
5. Rowen L. Toward a human papillomavirus vaccine. Dermatol Clinics. 1998;16:835-838.
6. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002;3:11-16.
7. Bosch F, Manos M, Nunoz N, Sherman M, Jansen A, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst. 1996;87:796-802.
8. Burd EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003;16:1.p.1-17.
9. a edición. Nueva York: Cold Spring Harbor Laboratory Press; 1989.
10. García L, Rodrigo J, Sánchez P, Ramos S, Suárez C. Extracción de ADN con resina Chelex en el análisis de la amplificación oncogénica en carcinoma de cabeza y cuello. Acta Otorrinolaringol Esp. 2004;55:139-144.
11. Bauer Hm, Greer CE, Manos MM. Detection of genital human papillomavirus infection using PCR. En: Herrington CS, McGee J. O. D, editores. Diagnostic molecular pathology: A practical approach. Oxford: Oxford University Press; 1992.p.131-152.
12. Manos M, Ting Y, Wright D, Lewis A, Broker T, Wolinsky S. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 1989;7:209-214.
13. Bernard HU, Chan S, Manos M, Ong CH, Villa L, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 1994;170:1077-1085.
14. Kurman R, Henson D, Herbst A, Noeller K, Schiffman M. Interim guidelines for management of abnormal cervical cytology. The 1992 National cancer Workshop. JAMA. 1994;271:1866-1869.
15. Nanda K, McCrory C, Myers E, Bastian L, Hasselblad V, Hickey J, et al. Accuracy of the Papanicolaou Test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med. 2000;132: 810-819.
16. Franco EL, Duarte-Franco E, Ferenczy A. Prospects for controlling cervical cancer at the turn of the century. Salud Publica Mex 2003;45(Suppl 3):367-375.
17. Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cel anemia. Science. 1985;230:1350-1354.
18. Lörincz AT, Schiffman MH, Jaffurs WJ, Marlowe J, Quinn AP, Temple GF. Temporal associations of human papillomavirus infection with cervical cytology abnormalities. Am J Obstet Gynecol. 1990;162:645-651.
19. Mendoza JA, Muñoz M, Vielma S, Noguera ME, López M, Toro M. Infección cervical por el virus papiloma humano: diagnóstico por citología y captura de híbridos del ADN viral. Rev Obstet Ginecol Venez. 2000;60:103-107.
20. Suárez CM, Mijares A, Marrero L, Briceño J. Tipificación del VPH en cáncer de cuello uterino. Rev Venez Oncol. 2006;18:221-225.
21. Villa L, Costa R, Petta A, Andrade R, Ault K. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II e. cacy trial. Lancet Oncol. 2005;6:271-278.